Pulsenmore Ltd. (TLV:PLSM)
Israel · Delayed Price · Currency is ILS · Price in ILA | Market Cap | 85.32M -56.4% |
| Revenue (ttm) | 9.31M +14.8% |
| Net Income | -44.00M |
| EPS | -6.89 |
| Shares Out | 6.50M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32,457 |
| Average Volume | 18,916 |
| Open | 1,190.00 |
| Previous Close | 1,213.00 |
| Day's Range | 1,190.00 - 1,347.00 |
| 52-Week Range | 1,190.00 - 4,312.00 |
| Beta | 0.23 |
| RSI | 21.21 |
| Earnings Date | Mar 27, 2026 |
About Pulsenmore
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient’s smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel. [Read more]
Financial Performance
In 2024, Pulsenmore's revenue was 9.66 million, an increase of 56.12% compared to the previous year's 6.19 million. Losses were -36.74 million, -37.28% less than in 2023.
Financial StatementsNews
Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance
OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a ma...
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in ...
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month pilot; Service to be deployed via Beilinson NEXT, Beilinson's virtual hospital RAMAT GAN, Israe...
Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that its shares will begin trading on Nasdaq at ...